Company profile
reMYND company profile
Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models. They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugs currently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept.
Business identity
- Website
- https://www.remynd.com/
- Contact email
- [email protected]
- Phone number
- +32 16 75 14 20
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2012-01-01, Year
Headquarters
- Headquarters
- Leuven, Flanders, Belgium
- Postal code
- BE-3001
- Country code
- BE
- Continent
- Europe